Open AccessCase Report: Kanamycin Ototoxicity and MDR-TB Treatment Regimen
Author(s) -
Bahru Mantefardo,
Gizaw Sisay
Publication year - 2021
Publication title -
international medical case reports journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.198
H-Index - 11
ISSN - 1179-142X
DOI - 10.2147/imcrj.s336259
Subject(s) - ototoxicity , medicine , hearing loss , regimen , tuberculosis , sputum , sputum culture , tinnitus , surgery , audiology , chemotherapy , pathology , cisplatin
Aminoglycosides are ototoxic drugs because they have the ability to destroy the inner ear structures irreversibly. They are used to treat Gram-negative bacterial infections that are aerobic and as a second-line treatment for tuberculosis.